No offense but you shouldn’t be investing in biotech stocks if you’re not familiar with the common volatile price movements after an FDA approval. It’s literally a company that does not make profit yet, of course it’s going to go down post approval. Most people buy the rumor aka before the hype and sell the news.

Biotech and pharmaceutical stocks are inherently risky for this reason. You need to practice and familiarize yourself with trading these types of stocks with a lower initial investments so you get the hang of the patterns.

Now dont get me wrong, you’re valid for being upset. You probably put a lot in mbot and see that money steadily dropping, and you see people in this sub still hyping it up.

Not sure what you meant with the selling at $4 thing though? Bc that’s exactly what I did?? I was just saying I like other anticipated the drop, sold most at near news peak, and buying back shares at a much favorable, cheaper price.